Integra Lifesciences Hld (IART)

Integra Lifesciences Hld (IART) Stock Quote Information

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for neurosurgery, extremity reconstruction, orthopedics, and general surgery primarily in the United States, Europe, and the Asia Pacific. Its orthopedics product portfolio comprises dermal regeneration and engineered wound dressings to treat the chronic wounds; nerve and tendon for the peripheral nerve repair and protection; bone and joint fixation devices and instruments for upper and lower extremity reconstruction; and bone graft substitutes for extremity reconstruction. The company?s spine and orthobiologics product portfolio includes spinal fusion devices for fusing two vertebrae; supplemental fixation systems for cervical procedures; interbody/vertebral body replacement devices to hold the graft in place to ensure a fusion; orthobiologic products for the repair and regeneration of bone in spinal and trauma surgery; and minimally invasive spine products. Integra?s neurosciences product portfolio includes duraplasty products for managing dural defects; tissue ablation equipment for the ablation of unwanted tissue; cerebral spinal fluid management devices for managing the intracranial pressure of a neuro-compromised patient; cranial stabilization equipment for fixing the head in an orientation determined by the surgeon; and intracranial monitoring equipment for monitoring intracranial pressure and metabolic activity. Its medical instruments product portfolio comprises room instrumentation and surgical lighting; and hand-held surgical instruments for the surgical, dental, podiatry, and animal health markets. The company sells its products directly through various sales forces and other distribution channels. Integra was founded in 1989 and is headquartered in Plainsboro, New Jersey.